Impfungen

Schlüsselwörter

Impfung - Influenza - Pneumokokken - Meningokokken - Masern - Reisemedizin

Keywords

vaccination - influenza - pneumococci - meningococci - measles - travel medicine

Literatur

• 1 Babcock H M, Gemeinhart N, Jones M, Dunagan W C, Woeltje K F. Mandatory influenza vaccination of health care workers: translating policy to practice.  Clin Infect Dis. 2010;  50 459-464
• 2 Blank P R, Schwenkglenks M, Szucs T D. Disparities in influenza vaccination coverage rates by target group in five European countries: trends over seven consecutive seasons.  Infection. 2009;  37 390-400
• 3 De Lencastre H, Kristinsson K G, Brito-Avo A. et al . Carriage of respiratory tract pathogens and molecular epidemiology of Streptococcus pneumoniae colonization in healthy children attending day care centers in Lisbon, Portugal.  Microb Drug Resist. 1999;  5 19-29
• 4 Dieleman J, Romio S, Johansen K. et al . Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe.  BMJ. 2011;  DOI: 10.1136/bmj.d4159
• 5 Dressel H, Nowak D. Grippeschutzimpfung im Gesundheitswesen: Stärkung der Eigenverantwortung oder Zwang?.  Dtsch Med Wochenschr. 2009;  DOI: 10.1136/bmj.d4159 134 1649
• 6 Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut / Stand: Juli 2011.  Epidem Bull. 2011;  30 275-294
• 7 European Medicines Agency recommends restricting use of Pandemrix. http://www.ema.europa.eu (27.7.2011)
• 8 Han F, Lin L, Warby S C. et al . Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in china.  Ann Neurol. 2011;  DOI: 10.1002/ana.22587
• 9 Hatz C, Werlein J, Mutsch M, Hufnagel M, Behrens R H. Japanese encephalitis: defining risk incidence for travelers to endemic countries and vaccine prescribing from the UK and Switzerland.  J Travel Med. 2009;  16 200-203
• 10 Hottes T S, Skowronski D M, Hiebert B. et al . Influenza vaccine effectiveness in the elderly based on administrative databases: change in immunization habit as a marker for bias.  PLoS One. 2011;  6 e22618
• 11 Huss A, Scott P, Stuck A E, Trotter C, Egger M. Efficacy of pneumococcal vaccination in adults: a meta-analysis.  CMAJ. 2009;  180 48-58
• 12 Imöhl M, Reinert R R, Mutscher C, van der Linden M. Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008.  BMC Microbiol. 2010;  10 299
• 13 Influenza Vaccination Coverage Among Healthcare Personnel – United States, 2010/11 Influenza Season.  MMWR. 2011;  60 1073-1077
• 14 Jefferson T, Di Pietrantonj C, Al-Ansary L A, Ferroni E, Thorning S, Thomas R E. Vaccines for preventing influenza in the elderly.  Cochrane Database Syst Rev. 2010; CD004876; 
• 15 Kwok R. Vaccines: The real issues in vaccine safety – hysteria about false vaccine risks often overshadows the challenges of detecting the real ones.  Nature. 2011;  473 436-438
• 16 Kwong J C, Stukel T A, Lim J, McGeer A J, Upshur R E. The effect of universal influenza immunization on mortality and health care use.  PLoS Med. 2008;  5 e211
• 17 Lewis S, Sadarangani M, Hoe J C, Pollard A J. Challenges and progress in the development of a serogroup B meningococcal vaccine.  Expert Rev Vaccines. 2009;  8 729-745
• 18 Liang X F, Li L, Liu D W. et al . Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China.  N Engl J Med. 2011;  364 638-647
• 19 Michiels B, Govaerts F, Remmen R, Vermeire E, Coenen S. A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups.  Vaccine. 2011;  Aug 12 [Epub ahead of print]
• 20 Miller E, Andrews N J, Waight P A, Slack M P, George R C. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales.  Lancet Infect Dis. 2011;  May 26 [Epub ahead of print]
• 21 Moberley S A, Holden J, Tatham D P, Andrews R M. Vaccines for preventing pneumococcal infection in adults.  Cochrane Database Syst Rev. 2008; CD000422; 
• 22 Nichol K L, Nordin J D, Nelson D B, Mullooly J P, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly.  N Engl J Med. 2007;  357 1373-1381
• 23 Pilishvili T, Lexau C, Farley M M. et al . Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.  J Infect Dis. 2010;  201 32-41
• 24 Poolman J, Borrow R. Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines.  Expert Rev Vaccines. 2011;  10 307-322
• 25 Rakita R M, Hagar B A, Crome P, Lammert J K. Mandatory influenza vaccination of healthcare workers: a 5-year study.  Infect Control Hosp Epidemiol. 2010;  31 881-888
• 26 Reichert T A, Sugaya N, Fedson D S, Glezen W P, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza.  N Engl J Med. 2001;  344 889-896
• 27 Reuss A M, Walter D, Feig M. et al . Influenzaimpfquoten der Saisons 2004/05, 2005/06 und 2006/07: Eine Sekundärdatenanalyse von Abrechnungsdaten der Kassenärztlichen Vereinigungen.  Dtsch Arztebl Int. 2010;  107 845-850
• 28 Robert-Koch-Institut .Grippeschutzimpfung in Deutschland – Ergebnisse der Studie „Gesundheit in Deutschland aktuell” (GEDA) 2009. http://www.rki.de letzter Zugriff 31.8.2011
• 29 Wicker S, Marckmann G, Poland G A, Rabenau H F. Health care workers’ perceptions of mandatory vaccination.  Infect Contr Hosp Epidemiol. 2010;  31 1066-1069
• 30 Wicker S, Rabenau H F, Ackermann H, Poland G A, Marckmann G. Rechtfertigt der Patientenschutz verpflichtende Impfungen? Ergebnisse einer anonymen Befragung von Medizinstudenten.  Dtsch Med Wochenschr. 2011;  136 1305-1311
• 31 Wicker S, Rabenau H F, Marckmann G, Sträter B, Pollandt B, Gottschalk R. Argumente für eine verpflichtende Influenzaimpfung.  Dtsch Med Wochenschr. 2009;  134 1650-1652